高级检索
当前位置: 首页 > 详情页

High resolution melting analysis: a rapid screening and typing tool for common β-thalassemia mutation in Chinese population.

文献详情

资源类型:
Pubmed体系:
机构: [1]Central Laboratory, Chaozhou Central Hospital Affiliated to Southern Medical University, Chaozhou, Guangdong Province, People’s Republic of China, [2]MedicalLaboratory, First Affiliated Hospital of Shantou University Medical College, Shantou, Guangdong Province, People’s Republic of China, [3]Department of Biology, HanshanNormal University, Chaozhou, Guangdong Province, People’s Republic of China, [4]Department of Medical Laboratory, Hospital of Youjiang Medical University forNationalities, Baise, Guangxi Province, People’s Republic of China, [5]Medical Laboratory, First Affiliated Hospital of Gannan Medical University, Ganzhou, Jiangxi Province,People’s Republic of China, [6]Laboratory Medical Center, People’s Hospital of Yunan Province, Kunming, Yunnan Province, People’s Republic of China, [7]Department ofMedical Laboratory, Chengdu Women’s & Children’s Central Hospital, Chengdu, Sichuan Province, People’s Republic of China, [8]Laboratory Medical Center, NanfangHospital, Southern Medical University, Guangzhou, Guangdong Province, People’s Republic of China, [9]Medical Laboratory, Meixian People’s Hospital, Meizhou,Guangdong Province, People’s Republic of China
出处:

摘要:
β-thalassemia is a common inherited disorder worldwide including southern China, and at least 45 distinct β-thalassemia mutations have been identified in China. High-resolution melting (HRM) assay was recently introduced as a rapid, inexpensive and effective method for genotyping. However, there was no systemic study on the diagnostic capability of HRM to identify β-thalassemia. Here, we used an improved HRM method to screen and type 12 common β-thalassemia mutations in Chinese, and the rapidity and reliability of this method was investigated. The whole PCR and HRM procedure could be completed in 40 min. The heterozygous mutations and 4 kinds of homozygous mutations could be readily differentiated from the melting curve except c.-78A>G heterozygote and c.-79A>G heterozygote. The diagnostic reliability of this HRM assay was evaluated on 756 pre-typed genomic DNA samples and 50 cases of blood spots on filter paper, which were collected from seven high prevalent provinces in southern China. If c.-78A>G heterozygote and c.-79A>G heterozygote were classified into the same group (c.-78&79 A>G heterozygote), the HRM method was in complete concordance with the reference method (reverse dot blot/DNA-sequencing). In a conclusion, the HRM method appears to be an accurate and sensitive method for the rapid screening and identification of β-thalassemia mutations. In the future, we suggest this technology to be used in neonatal blood spot screening program. It could enlarge the coverage of β-thalassemia screening program in China. At the same time, its value should be confirmed in prospectively clinical and epidemiological studies.

基金:
语种:
PubmedID:
中科院(CAS)分区:
出版当年[2014]版:
大类 | 3 区 生物
小类 | 3 区 综合性期刊
最新[2023]版:
大类 | 3 区 综合性期刊
小类 | 3 区 综合性期刊
第一作者:
第一作者机构: [1]Central Laboratory, Chaozhou Central Hospital Affiliated to Southern Medical University, Chaozhou, Guangdong Province, People’s Republic of China, [2]MedicalLaboratory, First Affiliated Hospital of Shantou University Medical College, Shantou, Guangdong Province, People’s Republic of China,
通讯作者:
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:82493 今日访问量:0 总访问量:681 更新日期:2025-01-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 云南省第一人民医院 技术支持:重庆聚合科技有限公司 地址:云南省昆明市西山区金碧路157号